Judge rejects Bayer injunction to block J&J alleged false statements on prostate cancer drug

 A federal judge rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its multibillion-dollar drug cuts the risk of death from prostate cancer in half.

In a Friday night decision, U.S. District Judge Dale Ho in Manhattan said Bayer was unlikely to succeed on the merits of its claims, which included that Johnson & Johnson's campaign for its drug Erleada caused irreparable harm and threatened to erode trust in Bayer's own drug Nubeqa.

https://www.msn.com/en-us/health/other/us-judge-rejects-bayer-s-bid-to-block-johnson-johnson-prostate-cancer-drug-claims/ar-AA219K9M